Study finds that the timing of meals, particularly late-night eating, is associated with an increased risk of cardiovascular disease, highlighting the importance of meal timing for cardiometabolic health.
AI-designed drug ISM5939 granted IND clearance for cancer clinical trials
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has received IND clearance from FDA for ISM5939, a potential
November 22, 2024